LifeVac receives FDA De Novo classification for anti-choking device
LifeVac has received De Novo classification from the US Food and Drug Administration (FDA) for its suction anti-choking device under…
09 Mar 2026
Aisa Pharma reports positive results for AISA-021
Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium channel blocker, for patients with systemic sclerosis-associated Raynaud’s phenomenon (SSc RP). The…
09 Mar 2026
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
Bristol Myers Squibb (BMS) has received the US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib), an oral selective tyrosine kinase 2 (TYK2) inhibitor, to treat adults with active…
06 Mar 2026
Cognita secures FDA breakthrough device designation for CXR
Cognita has received the US Food and Drug Administration (FDA) breakthrough device designation for the Chest X-Ray (CXR) model across multiple critical indications. Cognita operates as the AI division of…
06 Mar 2026
Seqster unveils 1-Click DataLake for clinical trials
Seqster has launched 1-Click DataLake, a real-world data platform to expedite trial design, recruitment, and evidence generation for healthcare and life sciences. The 1-Click DataLake draws on more than ten…
06 Mar 2026
Liberate Bio gains licences for myeloid-specific CAR design patents
Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to chimeric antigen receptor (CAR) designs tailored for myeloid cells, such as monocytes and macrophages. The licences sourced…
05 Mar 2026
Philips launches Rembra CT system for acute imaging
Philips has unveiled its next-generation radiology computed tomography (CT) system, Rembra, to address the challenges faced by acute and high-demand imaging settings. The solution has been introduced in response to…